Acutaas chemicals Limited has filed its quarterly compliance certificate with stock exchanges for the quarter ended March 31, 2026. The certificate was submitted to both BSE and NSE on April 02, 2026, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

The company submitted the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This regulation requires issuers and their Registrar and Transfer Agents to confirm the status of securities received from Depository Participants for dematerialisation during each quarter.

Certificate Confirmation

MUFG Intime India Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate. The certificate confirms that no dematerialisation requests were received during the quarter ended March 31, 2026. Consequently, no security certificates required mutilation or cancellation, and no substitution of depository names in the register of members was necessary.

Key Certificate Details

The compliance certificate addresses several critical aspects of securities handling:

• No dematerialisation requests were received from Depository Participants
• No securities were confirmed, accepted, or rejected during the quarter
• No security certificates required mutilation or cancellation
• No register of members updates were needed for depository substitutions

Regulatory Framework

Regulation 74(5) mandates that Registrar and Transfer Agents confirm the processing status of securities received for dematerialisation within prescribed timelines. This ensures transparency in the dematerialisation process and maintains accurate records of securities transactions. The regulation also requires confirmation that securities have been listed on appropriate stock exchanges where the company's securities are traded.

Corporate Governance

The filing was executed by CS Ekta Kumari Srivastava, Company Secretary and Compliance Officer, demonstrating the company's commitment to regulatory compliance. MUFG Intime India Private Limited, formerly Link Intime India Private Limited, continues to serve as the company's registered transfer agent, ensuring proper maintenance of shareholder records and compliance with depositories regulations.

Acutaas Chemicals Limited has successfully completed the acquisition of a controlling stake in Indichem Inc, a South Korean semiconductor chemicals company. The acquisition was executed through Acutaas Advance Material Limited, a wholly owned subsidiary of the company, which has acquired 75% shareholding in the joint venture company.

Acquisition Details

The transaction represents the completion of a joint venture agreement originally executed on June 27, 2025, between Acutaas Advance Material Limited and J & Materials Co. Ltd. With this acquisition, Indichem Inc has become a step-down subsidiary of Acutaas Chemicals Limited.

Target Company Profile

Indichem Inc operates in the semiconductor chemicals industry, focusing on the manufacture of specialty chemicals for semiconductor applications catering to South Korean and global markets. The company was newly incorporated in 2025, and its audited annual financial statements are yet to be prepared.

Strategic Rationale

The acquisition aligns with Acutaas Advance Material Limited's growth strategy for expansion into specialty chemicals for the semiconductor industry in the global market. This move significantly complements the company's existing product portfolio and positions it to capitalize on opportunities in the semiconductor chemicals sector.

Regulatory Compliance

The company has obtained requisite governmental and regulatory approvals in both India and South Korea under applicable laws of both countries. The transaction does not fall within related party transactions, ensuring arm's length dealing principles are maintained.

Manufacturing Development

Indichem Inc is currently in the construction and capex phase for its manufacturing plant in South Korea. The facility is scheduled to be commissioned by the end of the current calendar year, which will enable the company to commence commercial operations in the semiconductor chemicals market.